Director of Strategic Development and Market Access, PhD

Maria Rende, PhD is a Cell and Gene Therapy (CGT) subject-matter expert with over 20 years of experience, combining a strong scientific background with strategic business development and marketing expertise. After completing her PhD in Biochemical Engineering, Maria advanced her knowledge in Cell Therapy process development and manufacturing during her six years as a research associate at Imperial College London. She then transitioned into various business development roles.

In her most recent role at Sartorius, Maria led the Cell Therapy subject-matter expertise within the marketing team, where she was responsible for providing deep insights into cell therapy processes, understanding user requirements, and delivering market intelligence. Over the years, her technical expertise has contributed to the successful completion of multiple cell therapy projects, where she identified key process challenges and developed innovative solutions. Maria has also co-authored over sixty scientific publications and presented at numerous international conferences, meetings, and seminars.

Maria has now joined Aenitis as Director of Strategic Development and Market Access, where she continues to leverage her unique blend of scientific expertise and commercial insight. In this role, Maria is focused on bringing the company’s technology to market, driving innovation, and fostering strategic partnerships to ensure successful market access. We couldn’t be more thrilled to have Maria on board to help guide Aenitis’ mission and bring our cutting-edge technology into the market.